One-Year Functional, Cognitive, and Psychological Outcomes Following the Use of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Prospective Study

Supplemental Digital Content is available in the text. Objectives: To prospectively describe 1-year outcomes, with a focus on functional outcome, cognitive outcome, and the burden of anxiety, depression, and post-traumatic stress disorder, in coronavirus disease 2019 patients managed with extracorporeal membrane oxygenation. Design: Prospective case series. Setting: Tertiary extracorporeal membrane oxygenation center in the United States. Patients: Adult coronavirus disease 2019 acute respiratory distress syndrome patients managed with extracorporeal membrane oxygenation March 1, 2020, to July 31, 2020. Interventions: Baseline variables, treatment measures, and short-term outcomes were obtained from the medical record. Survivors were interviewed by telephone, a year following the index intensive care admission. Functional outcome was assessed using the modified Rankin Scale and the World Health Organization Disability Assessment Scale 2.0. Cognitive status was assessed with the 5-minute Montreal Cognitive Assessment. The Hospital Anxiety and Depression Scale was used to screen for anxiety and depression. Screening for post-traumatic stress disorder was performed with the Posttraumatic Stress Disorder Checklist 5 instrument. Measurements and Main Results: Twenty-three patients were managed with extracorporeal membrane oxygenation, 14 (61%) survived to hospital discharge. Thirteen (57%) were alive at 1 year. One patient was dependent on mechanical ventilation, another intermittently required supplemental oxygen at 1 year. The median modified Rankin Scale score was 2 (interquartile range, 1–2), median World Health Organization Disability Assessment Scale 2.0 impairment score was 21% (interquartile range, 6–42%). Six of 12 previously employed individuals (50%) had returned to work, and 10 of 12 (83%) were entirely independent in activities of daily living. The median Montreal Cognitive Assessment score was 14 (interquartile range, 13–14). Of 10 patients assessed with Hospital Anxiety and Depression Scale, 4 (40%) screened positive for depression and 6 (60%) for anxiety. Four of 10 (40%) screened positive for post-traumatic stress disorder. Conclusions: Functional impairment was common a year following the use of extracorporeal membrane oxygenation in coronavirus disease 2019, although the majority achieved independence in daily living and about half returned to work. Long-term anxiety, depression, and post-traumatic stress disorder were common, but cognitive impairment was not.

[1]  E. Moro,et al.  Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium , 2021, JAMA network open.

[2]  M. Kopelman,et al.  Long-term cognitive and psychiatric outcomes of acute respiratory distress syndrome managed with Extracorporeal Membrane Oxygenation. , 2021, Respiratory medicine.

[3]  A. Sestokas,et al.  Multi-institutional Analysis of 100 Consecutive Patients with COVID-19 and Severe Pulmonary Compromise Treated with Extracorporeal Membrane Oxygenation: Outcomes and Trends Over Time , 2021, ASAIO journal.

[4]  J. Maessen,et al.  Quality of life following adult veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review , 2021, Quality of Life Research.

[5]  M. E. Wilcox,et al.  Long-Term Cognitive Outcomes and Sleep in Adults After Extracorporeal Life Support , 2021, Critical care explorations.

[6]  K. Dams-O’Connor,et al.  Postintensive Care Syndrome in Survivors of Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic* , 2021, Critical care medicine.

[7]  Yimin Li,et al.  Functional disability and post-traumatic stress disorder in survivors of mechanical ventilation: a cross-sectional study in Guangzhou, China , 2021, Journal of thoracic disease.

[8]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization , 2021, ASAIO journal.

[9]  Jason Y. Adams,et al.  Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 , 2021, Intensive Care Medicine.

[10]  Hakeem O. Yusuff,et al.  Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19 , 2021, Journal of Cardiothoracic and Vascular Anesthesia.

[11]  J. Zwischenberger,et al.  Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative , 2020, JTCVS open.

[12]  E. Houdayer,et al.  COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience , 2020, medRxiv.

[13]  Ryan P. Barbaro,et al.  Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry , 2020, The Lancet.

[14]  D. Needham,et al.  Society of Critical Care Medicine’s International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness , 2020, Critical care medicine.

[15]  Arthur S Slutsky,et al.  Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.

[16]  R. Cerfolio,et al.  Extracorporeal Membrane Oxygenation Support in Severe COVID-19 , 2020, The Annals of Thoracic Surgery.

[17]  Shaojia Lu,et al.  The landscape of cognitive function in recovered COVID-19 patients , 2020, Journal of Psychiatric Research.

[18]  Xiao-Neng Mo,et al.  Abnormal pulmonary function in COVID-19 patients at time of hospital discharge , 2020, European Respiratory Journal.

[19]  A. Sestokas,et al.  Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients , 2020, ASAIO journal.

[20]  M. E. Wilcox,et al.  Long-Term Quality of Life After Extracorporeal Membrane Oxygenation in ARDS Survivors: Systematic Review and Meta-Analysis , 2020, Journal of intensive care medicine.

[21]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[22]  E. Ely,et al.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.

[23]  A. Scherag,et al.  Comparative validation of three screening instruments for posttraumatic stress disorder after intensive care. , 2019, Journal of critical care.

[24]  K. Baumstarck,et al.  Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients , 2019, Annals of Intensive Care.

[25]  N. Hawkins,et al.  Economic Evaluation of Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome* , 2019, Critical care medicine.

[26]  E. Fan,et al.  Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. , 2019, The Lancet. Respiratory medicine.

[27]  M. Ippolito,et al.  Long-term functional and psychological recovery in a population of ARDS patients treated with VV-ECMO and in their caregivers. , 2019, Minerva anestesiologica.

[28]  Mayur B. Patel,et al.  Co-Occurrence of Post-Intensive Care Syndrome Problems Among 406 Survivors of Critical Illness* , 2018, Critical care medicine.

[29]  S. Eksborg,et al.  Long-Term Cognitive Outcome and Brain Imaging in Adults After Extracorporeal Membrane Oxygenation , 2018, Critical care medicine.

[30]  J. Luciano,et al.  World Health Organization disability assessment schedule 2.0: An international systematic review , 2017, Disability and rehabilitation.

[31]  C. Hodgson,et al.  Recovery, Risks, and Adverse Health Outcomes in Year 1 After Extracorporeal Membrane Oxygenation , 2017, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[32]  Tracey Bucknall,et al.  The impact of disability in survivors of critical illness , 2017, Intensive Care Medicine.

[33]  Terence M Keane,et al.  Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. , 2016, Psychological assessment.

[34]  David C. Alsop,et al.  The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients , 2016, Alzheimer's & Dementia.

[35]  H. Wunsch,et al.  Risk of a Diagnosis of Dementia for Elderly Medicare Beneficiaries after Intensive Care , 2015, Anesthesiology.

[36]  T. Liou,et al.  Validation of the World Health Organization Assessment Schedule II Chinese Traditional Version (WHODAS II CT) in persons with disabilities and chronic illnesses for Chinese population , 2015, Disability and rehabilitation.

[37]  V. Mok,et al.  Montreal Cognitive Assessment 5-Minute Protocol Is a Brief, Valid, Reliable, and Feasible Cognitive Screen for Telephone Administration , 2015, Stroke.

[38]  Kevin T. Hansen,et al.  Correcting the MoCA for Education: Effect on Sensitivity , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[39]  P. Leprince,et al.  The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome , 2013, Intensive Care Medicine.

[40]  R. Hopkins The brain after critical illness: effect of illness and aging on cognitive function , 2013, Critical Care.

[41]  H. Wunsch,et al.  Risk factors for dementia after critical illness in elderly medicare beneficiaries , 2012, Critical Care.

[42]  A. Flint,et al.  Simple and reliable determination of the modified rankin scale score in neurosurgical and neurological patients: the mRS-9Q. , 2012, Neurosurgery.

[43]  Chris R Brewin,et al.  Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study , 2012, Critical Care.

[44]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[45]  A. Finset,et al.  The trajectory of physical and mental health from injury to 5 years after multiple trauma: a prospective, longitudinal cohort study. , 2012, Archives of physical medicine and rehabilitation.

[46]  D. Needham,et al.  Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders' conference* , 2012, Critical care medicine.

[47]  T. B. Üstün,et al.  Developing the World Health Organization Disability Assessment Schedule 2.0. , 2010, Bulletin of the World Health Organization.

[48]  P. M. Janssen,et al.  Comparison of Telephone and Face-to-Face Assessment of the Modified Rankin Scale , 2009, Cerebrovascular Diseases.

[49]  M. Wunderlich,et al.  WHODAS II with people after stroke and their relatives , 2009, Disability and rehabilitation.

[50]  G. Bernard,et al.  Risk factors for post-traumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study , 2007, Critical care.

[51]  R. Griffiths,et al.  Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care , 2001, Critical care medicine.

[52]  C. Gross,et al.  Intensive care unit drug use and subsequent quality of life in acute lung injury patients , 2000, Critical care medicine.

[53]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[54]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[55]  A. Swinburne,et al.  Return , 1888, The Hospital.